
PMC:7102662 / 11534-11630
Annnotations
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T173","span":{"begin":10,"end":14},"obj":"G_3;PG_10;PR:000003622"},{"id":"T174","span":{"begin":43,"end":47},"obj":"G_3;PG_10;PR:000003622"},{"id":"T175","span":{"begin":85,"end":95},"obj":"UBERON:0002349"}],"text":"le but roughly 8–12% of the positive cases are known to develop significant elevation of cTnI [1"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"357","span":{"begin":89,"end":93},"obj":"Gene"}],"attributes":[{"id":"A357","pred":"tao:has_database_id","subj":"357","obj":"Gene:7137"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"le but roughly 8–12% of the positive cases are known to develop significant elevation of cTnI [1"}